CFD analysis of a Mag-Lev ventricular assist device for infants and children: fourth generation design

Amy L Throckmorton1, Alexandrina Untaroiu

  • 1Department of Mechanical Engineering, Virginia Commonwealth University, Richmond, Virginia 23284-3015, USA. althrock@vcu.edu

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|July 23, 2008
PubMed

Insights

A new pediatric ventricular assist device (PVAD) shows promise for children with heart failure. Numerical simulations reveal the PVAD4 design reduces blood stress and damage compared to previous models.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Pediatric Medical Devices

Background:

  • Pediatric heart failure necessitates advanced mechanical circulatory support.
  • Limited viable mechanical assist devices are available for pediatric patients in the US.
  • Existing devices face challenges in long-term efficacy and patient outcomes.

Purpose of the Study:

  • To design and develop an improved axial flow pediatric ventricular assist device (PVAD).
  • To evaluate the performance and hemocompatibility of the novel PVAD4 design through numerical simulations.
  • To compare the PVAD4 design against its predecessor, the PVAD3, focusing on fluid dynamics and blood damage.

Main Methods:

  • Iterative design process culminating in the PVAD4 model.
  • Steady flow numerical simulations to assess pump performance.
  • Blood damage analysis using computational fluid dynamics to evaluate hemocompatibility.

Main Results:

  • The PVAD4 design demonstrated enhanced pressure generation capabilities (50-95 mm Hg).
  • Simulations indicated lower fluid stress levels in the PVAD4 compared to the PVAD3.
  • Blood damage analysis revealed a reduction in mean and maximum damage index for the PVAD4.

Conclusions:

  • The PVAD4 represents a significant advancement in pediatric ventricular assist device technology.
  • Numerical findings suggest improved hemocompatibility and performance, paving the way for a superior pump design.
  • Further development and testing are warranted to translate these findings into clinical application for pediatric heart failure patients.

Related Concept Videos